Trials / Completed
CompletedNCT04780074
Comparative Single-dose Bioavailability Study of Different CoQ10 Formulations
Comparative Single-dose Bioavailability Study of Different CoQ10 Formulations in Healthy Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Institute of Nutrition, Slovenia (Nutris) · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The single-center, randomized, open-label, five-period crossover single-dose bioavailability study with five CoQ10 formulations
Detailed description
The single-center, randomized, open-label, five-period crossover bioavailability study will include 30 subjects who will test five CoQ10 formulations. Study will be conducted with single dose CoQ10 to assess bioavailability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Single dose intervention with Standard product (SP) | 2 capsules - 200 mg total CoQ10 |
| DIETARY_SUPPLEMENT | Single dose intervention with Investigational product (IP1) | 2 softgels - 200 mg total CoQ10 |
| DIETARY_SUPPLEMENT | Single dose intervention with Investigational product (IP2) | 2 softgels - 200 mg total CoQ10 |
| DIETARY_SUPPLEMENT | Single dose intervention with Investigational product (IP3) | 2 softgels - 200 mg total CoQ10 |
| DIETARY_SUPPLEMENT | Single dose intervention with Investigational product (IP4) | 2 capsules - 200 mg total CoQ10 |
Timeline
- Start date
- 2021-02-28
- Primary completion
- 2021-05-21
- Completion
- 2022-12-13
- First posted
- 2021-03-03
- Last updated
- 2022-12-14
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT04780074. Inclusion in this directory is not an endorsement.